NHS
UK researchers warn NHS rollout of Mounjaro could widen inequalities in obesity care
由 AI 报道 AI 生成的图像 事实核查
UK specialists say strict early access rules for the weight-loss drug tirzepatide (Mounjaro) risk creating a “two-tier” obesity treatment system, with people who can pay privately getting faster access than those relying on the National Health Service.
The National Health Service in England will provide a new cream called ruxolitinib for treating non-segmental vitiligo, targeting the immune cells that cause skin pigmentation loss. Clinical trials showed it increased pigmentation in affected areas, offering a more targeted approach than existing options. The decision follows a reassessment by the National Institute for Health and Care Excellence, making it available for those aged 12 and older when other treatments fail.
由 AI 报道
A Cl0p ransomware attack has affected patient and staff data at Barts Health NHS. The breach occurred through the organization's Oracle E-Business Suite. Details emerged in a recent report on the incident.